Revelation Biosciences, Inc. (NASDAQ:REVB – Get Free Report) saw a large increase in short interest during the month of December. As of December 31st, there was short interest totalling 240,400 shares, an increase of 450.1% from the December 15th total of 43,700 shares. Based on an average daily volume of 2,980,000 shares, the short-interest ratio is presently 0.1 days. Approximately 2.9% of the shares of the company are short sold.
Revelation Biosciences Trading Down 5.5 %
Shares of NASDAQ REVB traded down $0.03 during midday trading on Monday, reaching $0.50. The company had a trading volume of 397,511 shares, compared to its average volume of 16,594,914. The business’s 50-day simple moving average is $0.60 and its 200 day simple moving average is $0.97. Revelation Biosciences has a 1 year low of $0.28 and a 1 year high of $25.26. The stock has a market cap of $2.15 million, a P/E ratio of -0.03 and a beta of 0.24.
About Revelation Biosciences
Recommended Stories
- Five stocks we like better than Revelation Biosciences
- What is the Dow Jones Industrial Average (DJIA)?
- 2 Stocks to Gain From Trump Universal Tariffs on Critical Imports
- Insider Trades May Not Tell You What You Think
- Rigetti Computing, Inc.: Buy, Sell, or Hold for 2025
- 3 Grocery Stocks That Are Proving They Are Still Essential
- Delta Can Fly to New Highs in 2025; Here’s Why
Receive News & Ratings for Revelation Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Revelation Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.